In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Sportradar Group AG (SRAD – Research Report). The company’s shares closed last Friday at $9.26.
According to TipRanks, Knickerbocker is a 3-star analyst with an average return of 3.3% and a 49.37% success rate. Knickerbocker covers the Healthcare sector, focusing on stocks such as Ironwood Pharma, Xtant Medical Holdings, and Avadel Pharmaceuticals.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sportradar Group AG with a $13.42 average price target.
SRAD market cap is currently $2.76B and has a P/E ratio of 74.26.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sportradar Group AG (SRAD) Company Description:
Sportradar Group AG is a technology platform enabling next-generation engagement in sports, and a provider of B2B solutions to the global sports betting industry. It generates revenue through two primary sources: subscription-based revenue and revenue sharing.
Read More on SRAD:
- SRAD Earnings this Week: How Will it Perform?
- Sportradar’s Alpha Odds Increased Profits By 15% for Operators Across UEFA Euro 2024 Qualifying Matches
- Sportradar to Participate in the J.P. Morgan Global Technology, Media and Communications Conference on May 21
- Sportradar Group AG Unveils Strategic Reorganization
- Bet On It: Recapping a week full of operator earnings
